Prostate Cancer - Results from #1320

Updated 5-year results for short course abiraterone acetate and LHRH agonist for unfavorable intermediate and favorable high-risk prostate cancer. February 26, 2024

Prostate Cancer Detection Rate of Transperineal Prostate Biopsy: Cognitive Versus Software Fusion, A Multicenter Analysis. February 26, 2024

Prostate-specific membrane antigen-positron emission tomography (PSMA-PET) of prostate cancer: current and emerging applications. February 26, 2024

A longitudinal mixed-methods study of pathology explanation clinics in patients with newly diagnosed localized prostate cancer. February 26, 2024

Development of CD46 targeted alpha theranostics in prostate cancer using 134Ce/225Ac-Macropa-PEG4-YS5. February 26, 2024

A Proposal for the Comprehensive Care of Men on Androgen Deprivation Therapy: Recommendations From the Multidisciplinary Prostate Cancer 360 Working Group. February 23, 2024

Addressing controversial areas in the management of advanced prostate cancer in Canada: Areas of consensus and controversy from the third Canadian consensus forum. February 23, 2024

Inherited Mutations in DNA Damage Repair Genes in Italian Men with Metastatic Prostate Cancer: Results from the Meet-URO 10 Study. February 23, 2024

Incidence and survival of secondary malignancies after external beam radiotherapy for prostate cancer in the Surveillance, Epidemiology, and End Results database. February 23, 2024

Clinical implications of AR alterations in advanced prostate cancer: a multi-institutional collaboration. February 23, 2024

Risk of Fractures and Falls in Men with Advanced or Metastatic Prostate Cancer Receiving Androgen Deprivation Therapy and Treated with Novel Androgen Receptor Signalling Inhibitors: A Systematic Review and Meta-analysis of Randomised Controlled Trials. February 23, 2024

Reversibility of Bicalutamide PSMA PET-Positive Gynecomastia With Androgen Deprivation Therapy. February 22, 2024

Gold nanoshells for prostate cancer treatment: evidence for deposition in abdominal organs. February 22, 2024

Stereotactic ablative radiation therapy in metastatic prostate cancer. February 22, 2024

Addition of cribriform pattern 4 and intraductal prostatic carcinoma into the CAPRA-S tool improves post-radical prostatectomy patient stratification in a multi-institutional cohort. February 22, 2024

Qualitative Study on Internet Use and Care Impact for Black Men With Prostate Cancer. February 22, 2024

Dissemination of circulating tumor cells in breast and prostate cancer: Implications for early detection. February 22, 2024

Oncologic Outcomes of Testosterone Therapy for Men on Active Surveillance for Prostate Cancer: A Population-based Analysis. February 21, 2024

Incidental Coronary Arterial Calcification for Cardiovascular Risk Assessment in Men With Prostate Cancer Undergoing PET/CT Imaging. February 21, 2024

Medication-based Comorbidity Measures and Prostate Cancer Treatment Selection. February 21, 2024

Page 67 of 1436